CARBIMAZOLE INDUCED CHOLESTATIC HEPATITIS
Article Sidebar
Main Article Content
Abstract
Thyrotoxicosis is a common disorder especially in women. Most of the patientstolerate antithyroid medications very well with very few developing life threatening side effects. A 64 years old gentleman was diagnosed with hyperthyroidismsecondary to Grave's disease (autoimmune). He was treated withCarbimazole 20 mg daily. With in a month, he presented with acute cholestatichepatitis. The patient's symptoms and laboratory abnormalities resolved afterwithdrawing the offending drug and controlling his thyroid status first withbeta blocker and subsequently with propylethioracil. Since the mechanism of liver damage is different, antithyroid medications can be interchanged withoutincreasing the risk of further liver damage.
Article Details
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.